Cargando…

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study

INTRODUCTION: In general, women more often experience metformin-associated adverse drug reactions (ADRs) than men. OBJECTIVES: We aimed to assess whether sex differences in reported ADRs for metformin are observed at different times after initiation, and to explore their concurrence with sex differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Sieta T., Denig, Petra, Ekhart, Corine, Mol, Peter G. M., van Puijenbroek, Eugene P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165141/ https://www.ncbi.nlm.nih.gov/pubmed/32048185 http://dx.doi.org/10.1007/s40264-020-00913-8

Ejemplares similares

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care
por: Denig, Petra, et al.
Publicado: (2019)

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
por: de Vries, Sieta T., et al.
Publicado: (2021)

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study
por: de Vries, Sieta T, et al.
Publicado: (2014)

Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors
por: Bots, Sophie H., et al.
Publicado: (2022)

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
por: Ekhart, Corine, et al.
Publicado: (2022)

Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020
por: Ambrož, Martina, et al.
Publicado: (2022)

Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients
por: de Vries, Sieta T., et al.
Publicado: (2018)

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands
por: de Vries, Esther, et al.
Publicado: (2020)

Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care
por: Ambrož, Martina, et al.
Publicado: (2022)

Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study
por: de Vries, Sieta T., et al.
Publicado: (2016)

Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study
por: Ambrož, Martina, et al.
Publicado: (2021)

Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire
por: Schreuder, Nanno, et al.
Publicado: (2020)

Trends in HbA(1c) thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients
por: Ambrož, Martina, et al.
Publicado: (2020)

Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana
por: Sabblah, George Tsey, et al.
Publicado: (2019)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
por: Zulzaga, Zuzaan, et al.
Publicado: (2021)

Changes in blood pressure thresholds for initiating antihypertensive medication in patients with diabetes: a repeated cross-sectional study focusing on the impact of age and frailty
por: Ambrož, Martina, et al.
Publicado: (2020)

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
por: Rolfes, Leàn, et al.
Publicado: (2016)

Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study
por: de Vries, Sieta T., et al.
Publicado: (2018)

Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands
por: Dittrich, Anne T. M., et al.
Publicado: (2020)

Sex differences in pharmacokinetics predict adverse drug reactions in women
por: Zucker, Irving, et al.
Publicado: (2020)

The Role of Patients’ Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes
por: de Vries, Sieta T., et al.
Publicado: (2015)

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
por: Rolfes, Leàn, et al.
Publicado: (2017)

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
por: Scholl, Joep H.G., et al.
Publicado: (2017)

Sex differences associated with adverse drug reactions resulting in hospital admissions
por: Hendriksen, L. C., et al.
Publicado: (2021)

Sex Differences in Response to Metformin in a Longitudinal Study in Mice
por: Teixeira, Camila Vieira Ligo, et al.
Publicado: (2020)

Unbearable Pruritus After Withdrawal of (Levo)cetirizine
por: Ekhart, Corine, et al.
Publicado: (2016)

Time to onset in statistical signal detection revisited: A follow‐up study in long‐term onset adverse drug reactions
por: Scholl, Joep H.G., et al.
Publicado: (2019)

Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient’s Perspective
por: van Lint, Jette A., et al.
Publicado: (2023)

What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study
por: Roldan Munoz, Sonia, et al.
Publicado: (2023)

Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward
por: Noorda, Nikki M. F., et al.
Publicado: (2022)

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands
por: de Vries, Esther, et al.
Publicado: (2022)

Attention for sex in COVID-19 trials: a review of regulatory dossiers
por: de Vries, Sieta T, et al.
Publicado: (2022)

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions
por: Reumerman, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rr307rkkukfq7nga1mh2qhgqdv